Learning More About the Study Drug, XEN1101, for Treating Focal Onset Seizures

About This Study

The purpose of this study is to find out if the study drug, XEN1101, can reduce seizure frequency. We also want to see if it is safe to use.

Need volunteers diagnosed with focal epilepsy who are experiencing focal seizures. The study will last about seven months. The study team will discuss study details with you.

What Activities Are a Part of this Study?

Informed Consent Review
Use of Study Treatments or Placebo
Review of Medical History
Physical Examinations
Study Visits and Consultations
Surveys/Questionnaires
Laboratory and Imaging Tests
Specimen Sample Collection
Diary/e-Diary Writing or Recordings

Age & Gender

18 - 100 years old
All Genders

Language

This study enrolls English and Spanish speakers

Additional Study Information

Compensation Offered
No reimbursement offered

Study Locations

Greater Winston-Salem, NC

Study Topics

Epilepsy Neurology Disorders

Study Locations and Contacts

Greater Winston-Salem, NC: Sara Tosh stosh@wakehealth.edu

Study Information
IRB Number: IRB00107842

Helpful Information

Have questions? See if your question is answered in our most common question and answers section. Need to know what something means? Browse the dictionary for explanation of common clinical study terms.